Loading market data...
Latest Top News
Show more
GSK Pharma Faces ₹18.1 Million Tax Demand, Including Fresh ₹2.6 Million Penalty
GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma), the Indian arm of global healthcare major GSK plc, has received a tax demand totaling ₹18.1 million from Indian authorities, including an additional ₹2.6 million levied as penalty and interest. The demand pertains to assessments under the Income T...
Stay Ahead – Explore Now! Axis Bank Shares Surge to Record High, Gain 3.5% on Strong Investor Sentiment






